Clinical investigation of the biological effects of a new combination low-dose oral contraceptive ('Ovostat E').
D000328:Adult; D001706:Biopsy; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D003279:Contraceptives, Oral, Sequential / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D004717:Endometrium / Q000187:drug effects; D004958:Estradiol / Q000097:blood; D004967:Estrogens / Q000652:urine; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008111:Liver Function Tests; D007986:Luteinizing Hormone / Q000652:urine; D008234:Lynestrenol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011276:Pregnanediol / Q000652:urine; D011374:Progesterone / Q000097:blood; D014626:Vaginal Smears
D003277:Contraceptives, Oral, Combined; D003279:Contraceptives, Oral, Sequential; D004967:Estrogens; D004997:Ethinyl Estradiol; D011374:Progesterone; D004958:Estradiol; C020414:Ministat; D007986:Luteinizing Hormone; D011276:Pregnanediol; D008234:Lynestrenol